Vertex Stands Ready To Launch First Drug In Its Pain Franchise

NaV Channel Research Has Been A Long Journey

 
• By Mandy Jackson
  
Vertex's suzetrigine launch is on track for early 2025, pending US FDA approval (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Scrip